LAG3 and neoplasm: The immune checkpoint lymphocyte-activation gene 3 (LAG-3) was reported to be expressed at higher levels on CD4+ and CD8+ T cells in TDLN of SCC patients compared to AC, but no significant differences were found in primary tumours [17,42].